Open Beta
TREN
MetriLume
TREN

US marketsMGX

SEC-sourced researchBeta

MGX

Metagenomi Therapeutics, Inc.

Company comparison ↗

Data passport

CIK
0001785279
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Sep 22, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 52,295,000.0000 USD; December 2025: 25,210,000.0000 USD52.3M USD0 USD0December 2024December 2025
MGX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202452,295,000.0000Mar 5, 2026
December 202525,210,000.0000Mar 5, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202525,210,000.0000-87,868,000.0000-88,892,000.0000221,103,000.000062,507,000.0000Mar 5, 2026
December 202452,295,000.0000-78,058,000.0000-109,073,000.0000324,599,000.000089,742,000.0000Mar 5, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$25.21MDecember 2025Mar 5, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$52.3MDecember 2024Mar 5, 202610-K
Net incomeNetIncomeLoss-$87.87MDecember 2025Mar 5, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$88.89MDecember 2025Mar 5, 202610-K
Total assetsAssets$221.1MDecember 2025Mar 5, 202610-K
Total liabilitiesLiabilities$62.51MDecember 2025Mar 5, 202610-K

New filings

Explore methodology ↗